{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:25:20Z","timestamp":1770675920202,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"DOI":"10.1093\/neuonc\/3.4.246","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T20:02:37Z","timestamp":1283284957000},"page":"246-250","source":"Crossref","is-referenced-by-count":4,"title":["Phase I study of Gliadel\u2122 wafers plus temozolomide in adults with\nrecurrent supratentorial high-grade gliomas"],"prefix":"10.1093","volume":"3","author":[{"given":"Sridharan","family":"Gururangan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkcan","family":"Cokgor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy N.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Lou","family":"Affronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"James E.","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Provenzale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger E.","family":"McLendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Tourt-Uhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Stafford-Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Zaknoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Early","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,10,1]]},"reference":[{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Belanich, M., Pastor, M., Randall, T., and Guerra, D., Kibitel, J.,\nAlas, L., Li, B., Citron, M., Wasserman, P., White, A., Eyre, H., Jaeckle, K.,\nSchulman, S., Rector, D., Prados, M., Coons, S., Shapiro, W., and Yarosh, D.\n(1996) Retrospective study of the correlation between the DNA\nrepair protein alkyltransferase and survival of brain tumor patients treated\nwith carmustine. Cancer Res.56,783\n-788.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Brem, H., Piantadosi, S., Burger, P.C., Walker, M., Selker, R.,\nVick, N.A., Black, K., Sisti, M., Brem, S., Mohr, G., Muller, P., Morawetz,\nR., and Schold, S.C., for the Polymer-Brain Tumor Treatment Group\n(1995) Placebo-controlled trial of safety and efficacy of\nintraoperative controlled delivery by biodegradable polymers of chemotherapy\nfor recurrent gliomas. Lancet345,1008\n-1012.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Chang, C.H., Horton, J., Schoenfeld, D., Salazer, O., Perez-Tamayo,\nR., Kramer, S., Weinstein, A., Nelson, J.S., and Tsukada, Y.\n(1983) Comparison of postoperative radiotherapy and combined\npostoperative radiotherapy and chemotherapy in the multidisciplinary\nmanagement of malignant gliomas. A joint Radiation Therapy Oncology Group and\nEastern Cooperative Oncology Group Study. Cancer52,997\n-1007.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Dolan, M.E., and Pegg. A.E., (1997)\nO6-benzylguanine and its role in chemotherapy. Clin.\nCancer Res.3,837\n-847.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Fine, H.A. (1994) The basis for current treatment\nrecommendations for malignant gliomas. J. Neurooncol.20,111\n-120.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Friedman, H.S., Dolan, M.E., Moschel, R.C., Pegg, A.E., Felker,\nG.M., Rich, J., Bigner, D.D., and Schold, S.C., Jr. (1992)\nEnhancement of nitrosourea activity in medulloblastoma and glioblastoma\nmultiforme. J. Natl. Cancer Inst.84,1926\n-1931.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Friedman, H.S., Johnson, S.P., Dong, Q., Schold, S.C., Rasheed,\nB.K., Bigner, S.H., Ali-Osman, F., Dolan, E., Colvin, O.M., Houghton, P.,\nGermain, G., Drummond, J.T., Keir, S., Marcelli, S., Bigner, D.D., and\nModrich, P. (1997) Methylator resistance mediated by mismatch\nrepair deficiency in a glioblastoma multiforme xenograft. Cancer\nRes.57,2933\n-2936.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Friedman, H.S., McLendon, R.E., Kerby, T., Dugan, M., Bigner, S.H.,\nHenry, A.J., Ashley, D.M., Krischer, J., Lovell, S., Rasheed, K., Marchev, F.,\nSeman, A.J., Cokgor, I., Rich, J., Stewart, E., Colvin, O.M., Provenzale,\nJ.M., Bigner, D.D., Haglund, M.M., Friedman, A.H., and Modrich, P.L.\n(1998) DNA mismatch repair and O6-alkylguanine-DNA\nalkyltransferase analysis and response to Temodal in newly diagnosed malignant\nglioma. J. Clin. Oncol.16,3851\n-3857.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Grossman, S.A., Reinhard, C., Colvin, O.M., Chasin, M., Brundrett,\nR., Tamargo, R.J., and Brem, H. (1992) The intracerebral\ndistribution of BCNU delivered by surgically implanted biodegradable polymers.\nJ. Neurosurg.76,640\n-647.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Hammond, L.A., Eckardt, J.R., Baker, S.D., Eckhardt, S.G., Dugan,\nM., Forral, K., Reidenberg, P., Statkevich, P., Weiss, G.R., Rinaldi, D.A.,\nVon Hoff, D.D., and Rowinsky, E.K. (1999) Phase I and\npharmacokinetic study of temozolomide on a daily-for-5 days schedule in\npatients with advanced solid malignancies. J. Clin.\nOncol.17,2604\n-2613.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Horspool, K.R., Stevens, M.F., Newton, C.G., Lunt, E., Walsh, R.J.,\nPedgrift, B.L., Baig, G.U., Lavelle, F., and Fizames, C. (1990)\nAntitumor imidazotetrazines. 20. Preparation of the 8-acid derivative of\nmitozolomide and its utility in the preparation of active antitumor agents.\nJ. Med. Chem.33,1393\n-1399.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Hotta, T., Saito, Y., Fujita, H., Mikami, T., Kurisu, K., Kiya, K.,\nUozumi, T., Isowa, G., Ishizaki, K., and Ikenaga, M. (1994)\nO6-alkylguanine-DNA alkyltransferase activity of human malignant\nglioma and its clinical implications. J. Neurooncol.21,135\n-140.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Jaeckle, K.A., Eyre, H.J., Townsend, J.J., Schulman, S., Knudson,\nH.M., Belanich, M., Yarosh, D.B., Bearman, S.I., Giroux, D.J., and Schold,\nS.C. (1998) Correlation of tumor O6-methylguanine-DNA\nmethyl transferase levels with survival of malignant astrocytoma in patients\ntreated with bis-chloroethylnitrosourea. A Southwest Oncology Group study.\nJ. Clin. Oncol.16,3310\n-3315.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Lage, H., and Dietel, M. (1999) Involvement of the DNA\nmismatch repair system in antineoplastic drug resistance. J. Cancer\nRes. Clin. Oncol.125,156\n-165.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Liu, L., Markowitz, S., and Gerson, S.L. (1996)\nMismatch repair mutations override alkyltransferase in conferring resistance\nto temozolomide but not to 1,3-bis (2-chlorethyl) nitrosourea.\nCancer Res.56,5375\n-5379.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Ludlum, D.B. (1990) DNA alkylation by the\nhaloethylnitrosoureas: Nature of modifications produced and their enzymatic\nrepair or removal. Mutat. Res.233,117\n-126.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Newlands, E.S., Blackledge, G.R., Slack, J.A., Rustin, G.J., Smith,\nD.B., Stuart, N.S., Quarterman, C.P., Hoffman, R., Stevens, M.F., and\nBrampton, M.H. (1992) Phase I trial of temozolomide (CCRG 81045:\nM&B 39831:NSC 362856). Br. J. Cancer65,287\n-291.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Pegg, A.E. (1990) Mammalian\nO6-alkylguanine-DNA alkyltransferase: Regulation and importance in\nresponse to alkylating carcinogenic and therapeutic agents. Cancer\nRes.50,6119\n-6129.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Plowman, J., Waud, W.R., Koutsoukos, A.D., Rubinstein, L.V., Moore,\nT.D., and Grever, M.R. (1994) Preclinical antitumor activity of\ntemozolomide in mice: Efficacy against human brain tumor xenografts and\nsynergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer\nRes.54,3793\n-3799.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Schold, S.C., Jr., Kuhn, J.G., Chang, S.M., Bosik, M.E., Robins,\nH.I., Mehta, M.P., Spence, A.M., Fulton, D., Fink, K.L., and Prados, M.D.\n(2000) A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea\nplus temozolomide. A North American Brain Tumor Consortium study.\nNeuro-Oncology [serial online], Doc. 99-26, December 9, 1999. URL\nhttp:\/\/neuro-oncology.mc.duke.edu.\nNeuro-Oncol.2,34\n-39.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Walker, M.D., Green, S.B., Byar, D.P., Alexander, E., Jr.,\nBatzdorf, U., Brooks, W.H., Hunt, W.E., MacCarty, C.S., Mahaley, M.S., Jr.,\nMealey, J., Jr., Owens. G., Ransohoff, J., II, Robertson, J.T., Shapiro, W.R.,\nSmith, K.R., Jr., Wilson, C.B., and Strike, T.A. (1980)\nRandomized comparisons of radiotherapy and nitrosoureas for treatment of\nmalignant glioma after surgery. N. Engl. J. Med.303,1323\n-1329.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Wedge, S.R., Porteus, J.K., and Newlands, E.S. (1996)\n3-aminobenzamide and\/or O6-benzylguanine evaluated as an adjuvant\nto temozolomide or BCNU treatment in cell lines of variable mismatch repair\nstatus and O6-alkylguanine-DNA alkyltransferase activity.\nBr. J. Cancer74,1030\n-1036.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Yung, W.K.A., Prados, M.D., Yaya-Tur, R., Rosenfeld, S.S., Brada,\nM., Friedman, H.S., Albright, R., Olson, J., Chang, S.M., O'Neill, A.M.,\nFriedman, A.H., Bruner, J., Yue, N., Dugan, M., Zaknoen, S., and Levin, V.A.\n(1999) Multicenter phase II trial of temozolomide in patients\nwith anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse.\nJ. Clin. Oncol.17,2762\n-2771.","DOI":"10.1054\/bjoc.2000.1316"},{"key":"key\n\t\t\t\t20171013054248_","doi-asserted-by":"crossref","unstructured":"Yung, W.K.A., Albright, R.E., Olson, J., Fredericks, R., Fink, K.,\nPrados, M.D., Brada. M., Spence, A., Hohl, R.J., Shapiro, W., Glantz, M.,\nGreenberg, H., Selker, R.G., Vick, N.A., Rampling, R., Friedman, H., Phillips,\nP., Bruner, J., Yue, N., Osoba, D., Zaknoen, S., and Levin, V.A.\n(2000) A phase II study of temozolomide vs. procarbazine in\npatients with glioblastoma multiforme at first relapse. Br. J.\nCancer83,588\n-593.","DOI":"10.1054\/bjoc.2000.1316"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/3\/4\/246\/13065663\/p246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T09:45:23Z","timestamp":1507887923000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/3\/4\/246\/1067630\/Phase-I-study-of-Gliadel-wafers-plus-temozolomide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,10,1]]},"published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/3.4.246","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,10]]},"published":{"date-parts":[[2001,10,1]]}}}